Jefferies Group's position in Incyte is currently worth $2.45 Million. That's 0.03% of their equity portfolio (344th largest holding). The first Incyte trade was made in Q4 2022. Since then Jefferies Group bought shares three more times and sold shares on three occasions. The investor's estimated purchase price is $3.05 Million, resulting in a loss of 20%.
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Monday. Shares of Overseas Shipholding Group, Inc . (NYSE: OSG ) rose sharply...
MorphoSys AG / Key word(s): Forecast Ad hoc: MorphoSys AG Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial G...
… during the quarter. Russell Investments Group Ltd. owned approximately … the period. Finally, Contravisory Investment Management Inc. grew its … funds and ...
MorphoSys AG / Key word(s): Change in Forecast Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Gu...